Cspc Megalith Biopharmaceutical Co.,ltd.
Clinical trials sponsored by Cspc Megalith Biopharmaceutical Co.,ltd., explained in plain language.
-
New hope for Tough-to-Treat lung cancer: experimental drug takes on chemo in major trial
Disease control Recruiting nowThis study is testing whether a new drug called SYS6010 works better and is safer than standard platinum-based chemotherapy for people with a specific type of advanced lung cancer (EGFR-mutated NSCLC) that has stopped responding to previous targeted therapies. It will involve abo…
Phase: PHASE3 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Apr 04, 2026 02:06 UTC
-
New drug duo tested in battle against tough head and neck cancers
Disease control Recruiting nowThis study is testing whether a new combination of two drugs, SYS6010 and enlonstobart, can help control advanced head and neck cancer that has returned or spread. It will involve about 70 adults whose cancer is not suitable for surgery or standard radiation/chemotherapy. The mai…
Phase: PHASE2 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New cancer drug shows promise in early trials for Tough-to-Treat tumors
Disease control Recruiting nowThis early-stage trial is testing a new drug called SYS6043 in people with advanced solid tumors that have spread or returned after standard treatments. Researchers will first determine safe dosage levels, then expand to study how the drug behaves in the body and whether it helps…
Phase: PHASE1, PHASE2 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC